About Biorelate
Biorelate is a company based in Manchester (United Kingdom) founded in 2014 by Daniel Jamieson.. Biorelate has raised $8.74 million across 4 funding rounds from investors including Maven Capital Partners, Triple Point and YFM Equity Partners. Biorelate offers products and services including Galactic AI and Knowledge Graphs. Biorelate operates in a competitive market with competitors including Science Exchange, Bioz, Naicons, LIFE & BRAIN and Sciformix Corporation, among others.
- Headquarter Manchester, United Kingdom
- Founders Daniel Jamieson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Biorelate Limited
- Date of Incorporation 16 Jun, 2014
- Jurisdiction MANCHESTER, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8.74 M (USD)
in 4 rounds
-
Latest Funding Round
$7.82 M (USD), Series A
Nov 29, 2022
-
Investors
Maven Capital Partners
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biorelate
Biorelate offers a comprehensive portfolio of products and services, including Galactic AI and Knowledge Graphs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
AI for curating biomedical data and relationships.
Tool for building and analyzing biomedical knowledge networks.
Unlock access to complete
Funding Insights of Biorelate
Biorelate has successfully raised a total of $8.74M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $7.82 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series A — $7.8M
- First Round First Round
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series A - Biorelate | Valuation | YFM Equity Partners , Maven Capital Partners | |
| Feb, 2019 | Amount | Grant - Biorelate | Valuation |
investors |
|
| Sep, 2018 | Amount | Seed - Biorelate | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biorelate
Biorelate has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Maven Capital Partners, Triple Point and YFM Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Multiple sectors are targeted for private equity investments.
|
Founded Year | Domain | Location | |
|
Private debt is extended to early-stage companies and SMEs.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biorelate
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biorelate
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biorelate Comparisons
Competitors of Biorelate
Biorelate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Science Exchange, Bioz, Naicons, LIFE & BRAIN and Sciformix Corporation, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Scientific research is outsourced via an online marketplace platform.
|
|
| domain | founded_year | HQ Location |
Developer of AI search engine for scientific experimentation
|
|
| domain | founded_year | HQ Location |
Developer of bioactive compounds for drug-resistant bacterial infections
|
|
| domain | founded_year | HQ Location |
Biomedical and neuroscientific technologies are researched and developed.
|
|
| domain | founded_year | HQ Location |
Scientific process outsourcing is delivered for life sciences firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biorelate
Frequently Asked Questions about Biorelate
When was Biorelate founded?
Biorelate was founded in 2014 and raised its 1st funding round 2 years after it was founded.
Where is Biorelate located?
Biorelate is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Who is the current CEO of Biorelate?
Daniel Jamieson is the current CEO of Biorelate. They have also founded this company.
Is Biorelate a funded company?
Biorelate is a funded company, having raised a total of $8.74M across 4 funding rounds to date. The company's 1st funding round was a Seed of $914.55K, raised on Mar 06, 2016.
What does Biorelate do?
Founded in 2014 and based in Manchester, United Kingdom, Biorelate operates in the biotechnology sector with a focus on AI applications. An AI-driven knowledge graph is developed to support biomedical target identification, drug discovery, and validation of target lists. Tools are offered for analyzing mechanisms of action and target-drug-disease relationships. Causal insights from diverse sources are integrated to reveal undescribed connections in biomedical research.
Who are the top competitors of Biorelate?
Biorelate's top competitors include Science Exchange, Bioz and Naicons.
What products or services does Biorelate offer?
Biorelate offers Galactic AI and Knowledge Graphs.
Who are Biorelate's investors?
Biorelate has 8 investors. Key investors include Maven Capital Partners, Triple Point, YFM Equity Partners, Northern Powerhouse Investment Fund, and Innovate UK.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.